Delcath Systems Inc. (DCTH) NASDAQ

$4.86 (0.09) (-1.82%)

Market Cap: $121.59M

As of 04/15/24 03:58 PM EDT. Market closed.

(DCTH)

Delcath Systems Inc. (DCTH)
NASDAQ

$4.86
(0.09) (-1.82%)

Market Cap: $121.59M

As of 04/15/24 03:58 PM EDT. Market closed.

Add to Portfolio

delcath systems, inc. (nasdaq- dcth) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. our proprietary product---melphalan hydrochloride for injection for use with the delcath hepatic delivery system (melphalan/hds)---is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure. delcath ... read more

delcath systems, inc. (nasdaq- dcth) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. our proprietary product---melphalan hydrochloride for injection for use with the delcath hepatic delivery system (melphalan/hds)---is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure. delcath is in late-stage clinical development in the united states with initial commercial activities in europe, where the melphalan/hds is marketed as a ce marked device under the trade name delcath hepatic chemosat® delivery system for melphalan (chemosat). our commercial strategy for chemosat is to steadily grow clinical adoption in major european markets and utilize physician experience to support appeals for reimbursement. since launch over 250 chemosat treatments have been performed at over 20 leading european cancer centers. in 2016, we launched our focus pivotal study in hepatic dominant ocular read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO
Jennifer Simpson
Full Time Employees
44
URL
Address
1633 Broadway Ste 22C, New York, New York, 10019-6708.
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO
Jennifer Simpson
Full Time Employees
44
Address
1633 Broadway Ste 22C, New York, New York, 10019-6708.
PRICE CHART FOR DELCATH SYSTEMS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.98
Previous Close
$4.95
Days Range
$4.85 - $5
52 week range
$2.25 - $7.99
Volume
182,196
Avg. Volume (30 days)
258,338
Market Cap
$121.59M
Dividend Yield
-
P/E
-
Shares Outstanding
24,562,692
Open
$4.98
Previous Close
$4.95
Days Range
$4.85 - $5
52 week range
$2.25 - $7.99
Volume
182,196
Avg. Volume (30 days)
258,338
Market Cap
$121.59M
Dividend Yield
-
P/E
-
Shares Outstanding
24,562,692
FINANCIAL STATEMENTS FOR DELCATH SYSTEMS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR DELCATH SYSTEMS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Aharon GilDirectorMar 19, 2024 Buy$3.7226,882100,0011,069,710Mar 20, 2024, 08:00 PM
SALAMON STEVEN A JDirectorMar 19, 2024 Buy$3.7226,882100,0011,121,025Mar 20, 2024, 07:44 PM
Vukovic VojoCHIEF MEDICAL OFFICERMar 19, 2024 Option Exercise$3.7226,882100,001126,882Mar 19, 2024, 05:03 PM
MICHEL GERARD JCHIEF EXECUTIVE OFFICERMar 19, 2024 Option Exercise$3.7240,323150,002302,668Mar 19, 2024, 05:01 PM
Pennell SandraSVP OF FINANCE, PFO AND PAOMar 19, 2024 Option Exercise$3.7226,88199,99761,052Mar 19, 2024, 04:59 PM
Muir KevinGM INTERVENTIONAL ONCOLOGYMar 19, 2024 Option Exercise$3.7213,44150,00118,582Mar 19, 2024, 04:58 PM
Hoffman David L.GEN'L COUNSEL, CCO & SECYMar 19, 2024 Option Exercise$3.7220,16174,99974,330Mar 19, 2024, 04:57 PM
Vukovic VojoChief Medical OfficerDec 12, 2023 Buy$3.0040,000120,000100,000Dec 14, 2023, 04:20 PM
MICHEL GERARD JChief Executive OfficerDec 08, 2023 Buy$2.9434,00099,960262,345Dec 11, 2023, 05:02 PM
Rosalind Advisors, Inc.DirectorNov 17, 2023 Buy$2.40100,000240,4101,038,828Nov 21, 2023, 11:07 AM
Pennell SandraSVP of Finance, PFO and PAONov 17, 2023 Buy$2.4330,00072,90030,000Nov 21, 2023, 07:42 AM
Vukovic VojoChief Medical OfficerNov 16, 2023 Buy$2.4860,000148,80060,000Nov 20, 2023, 04:22 PM
Hoffman David L.See RemarksNov 16, 2023 Buy$2.4840,00099,20040,000Nov 20, 2023, 04:20 PM
Purpura JohnChief Operating OfficerOct 13, 2023 Buy$3.4414,50549,89741,526Oct 17, 2023, 04:53 PM
Sylvester John RichardDirectorAug 21, 2023 Buy$4.8010,55050,64010,550Aug 23, 2023, 11:03 AM
MICHEL GERARD JChief Executive OfficerAug 18, 2023 Option Exercise$4.5031,110139,995228,345Aug 21, 2023, 12:05 PM
MICHEL GERARD JChief Executive OfficerMar 29, 2023 Buy$4.8419,64695,087197,235Mar 30, 2023, 09:00 AM
Rosalind Advisors, Inc.DirectorDec 14, 2022 Buy$3.6215,21555,045459,315Dec 16, 2022, 09:32 AM
SALAMON STEVEN A JDirectorDec 14, 2022 Buy$3.6215,21555,045455,315Dec 16, 2022, 09:22 AM
MICHEL GERARD JChief Executive OfficerDec 13, 2022 Buy$2.9051,725150,003177,589Dec 14, 2022, 03:33 PM
MICHEL GERARD JChief Executive OfficerJul 20, 2022 Buy$3.9862,814250,000125,864Jul 21, 2022, 10:29 AM
Purpura JohnChief Operating OfficerMay 16, 2022 Buy$4.613,30015,21327,021May 18, 2022, 10:42 AM
SALAMON STEVEN A JDirectorMay 13, 2022 Buy$5.035,00025,135440,100May 16, 2022, 12:04 PM
SALAMON STEVEN A JDirectorMay 12, 2022 Buy$4.906,00029,42429,424May 13, 2022, 12:12 PM
Rosalind Advisors, Inc.DirectorApr 19, 2022 Buy$6.251,60010,000433,100Apr 21, 2022, 12:42 PM
SALAMON STEVEN A JDirectorApr 19, 2022 Buy$6.251,60010,000429,100Apr 20, 2022, 03:47 PM
Rosalind Advisors, Inc.DirectorApr 18, 2022 Buy$6.352,00012,697431,500Apr 19, 2022, 01:52 PM
Aharon GilDirectorApr 18, 2022 Buy$6.352,00012,697404,000Apr 19, 2022, 01:52 PM
MICHEL GERARD JSee RemarksApr 18, 2022 Buy$6.372,00012,73463,050Apr 18, 2022, 09:23 PM
Rosalind Advisors, Inc.DirectorApr 13, 2022 Buy$6.451,5009,675429,500Apr 14, 2022, 05:20 PM
SALAMON STEVEN A JDirectorApr 13, 2022 Buy$6.451,5009,675427,500Apr 14, 2022, 01:47 PM
Rosalind Advisors, Inc.DirectorApr 12, 2022 Buy$6.482,50016,200428,000Apr 12, 2022, 06:42 PM
SALAMON STEVEN A JDirectorApr 12, 2022 Buy$6.482,50016,200425,000Apr 12, 2022, 05:58 PM
Purpura JohnChief Operating OfficerApr 11, 2022 Buy$6.595,00032,95023,721Apr 11, 2022, 04:11 PM
MICHEL GERARD JSee RemarksApr 08, 2022 Buy$6.572,00013,13661,050Apr 08, 2022, 06:25 PM
SALAMON STEVEN A JDirectorApr 07, 2022 Buy$6.411,0006,410423,500Apr 08, 2022, 11:23 AM
SALAMON STEVEN A JDirectorApr 06, 2022 Buy$6.491,0006,490422,500Apr 08, 2022, 11:23 AM
Rosalind Advisors, Inc.DirectorApr 07, 2022 Buy$6.411,0006,410425,500Apr 08, 2022, 09:43 AM
Rosalind Advisors, Inc.DirectorApr 06, 2022 Buy$6.491,0006,490424,500Apr 08, 2022, 09:43 AM
Purpura JohnChief Operating OfficerNov 19, 2020 Buy$12.681,60020,28814,721Apr 05, 2022, 04:58 PM
SALAMON STEVEN A JDirectorDec 30, 2021 Buy$7.562,00015,120421,500Jan 03, 2022, 02:04 PM
Rosalind Advisors, Inc.DirectorDec 30, 2021 Buy$7.562,00015,120423,500Jan 03, 2022, 02:02 PM
MICHEL GERARD JSee RemarksDec 02, 2021 Buy$8.6123,200199,75259,050Dec 06, 2021, 06:06 PM
SALAMON STEVEN A JDirectorJun 30, 2021 Buy$12.765,50070,180419,500Jul 01, 2021, 10:47 AM
Rosalind Advisors, Inc.DirectorJun 30, 2021 Buy$12.765,50070,180421,500Jul 01, 2021, 10:45 AM
Rosalind Advisors, Inc.DirectorJun 28, 2021 Buy$11.565,00057,800416,000Jul 01, 2021, 10:44 AM
SALAMON STEVEN A JDirectorJun 28, 2021 Buy$11.565,00057,800414,000Jun 30, 2021, 09:53 AM
Rosalind Advisors, Inc.DirectorJun 28, 2021 Buy$11.56500,0005,780,000416,000Jun 30, 2021, 09:52 AM
MICHEL GERARD JChief Executive OfficerJun 28, 2021 Buy$11.936,25074,56335,850Jun 29, 2021, 01:46 PM
MICHEL GERARD JChief Executive OfficerJun 25, 2021 Buy$11.356,60074,91029,600Jun 29, 2021, 01:46 PM
SALAMON STEVEN A JDirectorJun 24, 2021 Buy$10.904,50049,050409,000Jun 28, 2021, 08:50 AM
Purpura JohnChief Operating OfficerMay 13, 2021 Buy$9.424,00037,68018,713May 14, 2021, 08:06 AM
SALAMON STEVEN A JDirectorMar 31, 2021 Option Exercise$10.00215,0002,150,000404,500Apr 01, 2021, 04:24 PM
Rosalind Advisors, Inc.DirectorMar 31, 2021 Option Exercise$10.00215,0002,150,000406,500Apr 01, 2021, 04:23 PM
Aharon GilDirectorMar 31, 2021 Option Exercise$10.00215,0002,150,000402,000Apr 01, 2021, 04:22 PM
MICHEL GERARD JChief Executive OfficerDec 11, 2020 Buy$13.257,50099,3757,500Dec 14, 2020, 02:00 PM
Purpura JohnChief Operating OfficerNov 19, 2020 Buy$12.681,60020,28814,713Nov 20, 2020, 04:05 PM
Rosalind Advisors, Inc.DirectorNov 17, 2020 Buy$12.112,50030,280191,500Nov 19, 2020, 02:27 PM
SALAMON STEVEN A JDirectorNov 17, 2020 Buy$12.112,50030,280189,500Nov 17, 2020, 12:37 PM
Rosalind Advisors, Inc.DirectorNov 13, 2020 Buy$11.754,00047,000189,000Nov 16, 2020, 01:21 PM
Aharon GilDirectorNov 16, 2020 Buy$12.002,00024,000187,000Nov 16, 2020, 01:20 PM
SALAMON STEVEN A JDirectorNov 13, 2020 Buy$11.512,00023,020187,000Nov 13, 2020, 01:43 PM
Purpura JohnEVP, Global OperationsSep 28, 2018 Buy$1.755,5009,6255,501Oct 23, 2018, 04:20 PM
STOLL ROGER G PHDDirectorSep 28, 2018 Buy$1.754,9008,5755,901Oct 23, 2018, 04:19 PM
Simpson Jennifer K.President & CEOSep 28, 2018 Buy$1.757,39912,9487,500Oct 23, 2018, 04:16 PM
Keck BarbraChief Financial OfficerSep 28, 2018 Buy$1.757,39912,9487,500Oct 23, 2018, 04:16 PM
Rueckert William DodgeDirectorSep 28, 2018 Buy$1.756,50011,3757,926Oct 23, 2018, 04:16 PM
STOLL ROGER G PHDDirectorAug 01, 2018 Buy$2.471,0002,4661,001Aug 02, 2018, 09:25 PM
Rueckert William DodgeDirectorJul 31, 2018 Buy$2.533,2088,1033,209Aug 02, 2018, 09:06 PM
Keck BarbraChief Financial OfficerAug 01, 2018 Buy$2.39100239101Aug 02, 2018, 07:17 PM
Simpson Jennifer K.President & CEOJul 31, 2018 Buy$2.55100255101Aug 02, 2018, 07:01 PM
Simpson Jennifer K.President & CEOJun 27, 2017 Option Exercise$0.2246810241,908Jun 29, 2017, 04:30 PM
Purpura JohnEVP, Regulatory AffairsJun 27, 2017 Option Exercise$0.222305035,398Jun 29, 2017, 04:30 PM
Keck BarbraChief Financial OfficerJun 27, 2017 Option Exercise$0.221683723,887Jun 29, 2017, 04:30 PM
Keck BarbraSenior VP, FinanceJun 16, 2016 Option Exercise$0.258,5612,14064,926Jun 17, 2016, 04:04 PM
Purpura JohnEVP, Regulatory AffairsJun 16, 2016 Option Exercise$0.2511,7382,93590,074Jun 17, 2016, 04:03 PM
Simpson Jennifer K.President & CEOJun 16, 2016 Option Exercise$0.2524,0046,001178,292Jun 17, 2016, 04:03 PM
STOLL ROGER G PHDDirectorJul 27, 2015 Buy$0.5420,00010,74099,145Jul 28, 2015, 05:05 PM
Taglietti MarcoDirectorJul 28, 2015 Buy$0.54100,00054,433220,000Jul 28, 2015, 03:50 PM
Taglietti MarcoDirectorJul 27, 2015 Buy$0.52100,00052,350120,000Jul 28, 2015, 03:50 PM
Philips Laura ADirectorJul 23, 2015 Buy$0.5091,01145,333205,299Jul 24, 2015, 04:56 PM
Philips Laura ADirectorJul 22, 2015 Buy$0.4971,64235,376114,288Jul 24, 2015, 04:56 PM
Rueckert William DodgeDirectorJul 22, 2015 Buy$0.4820,0009,58040,000Jul 22, 2015, 05:54 PM
LEUNG GABRIELDirectorJun 15, 2012 Buy$1.577,50011,76115,847Jun 18, 2012, 04:05 PM
Philips Laura ADirectorJun 01, 2012 Buy$1.5165,00098,049130,854Jun 04, 2012, 05:31 PM
WATSON DOUGLAS GDirectorJun 01, 2012 Buy$1.5150,00075,27561,369Jun 04, 2012, 05:23 PM
Koplewicz Harold SDirectorJun 01, 2012 Buy$1.4966,66799,454148,521Jun 04, 2012, 04:56 PM
Purpura JohnEVP Reg. Affairs/Quality AssurJun 01, 2012 Buy$1.495,0007,45020,000Jun 04, 2012, 04:52 PM
HOBBS EAMONN PPresident and CEOJun 01, 2012 Buy$1.527,00010,611162,000Jun 04, 2012, 04:47 PM
Simpson Jennifer K.Exec. VP, Global MarketingJun 01, 2012 Buy$1.493,0004,47010,750Jun 04, 2012, 04:43 PM
Miao Graham GExec. V.P., CFOMay 31, 2012 Buy$1.5020,00030,00054,000Jun 04, 2012, 04:25 PM
Kandarpa KrishnaExec. V.P., Chief Medical Off.Jan 06, 2012 Sale$3.7534,606129,790150,000Jan 06, 2012, 04:57 PM
LADD ROBERTDirectorDec 23, 2011 Sale$2.4710,00024,660631,294Dec 23, 2011, 05:50 PM
LADD ROBERTDirectorDec 22, 2011 Sale$2.4410,00024,421641,294Dec 23, 2011, 05:50 PM
LADD ROBERTDirectorDec 20, 2011 Sale$1.9510,00019,500661,294Dec 21, 2011, 05:35 PM
LADD ROBERTDirectorDec 21, 2011 Sale$2.0010,00020,000651,294Dec 21, 2011, 05:35 PM
LADD ROBERTDirectorDec 19, 2011 Sale$1.9210,00019,185671,294Dec 19, 2011, 06:20 PM
LADD ROBERTDirectorDec 16, 2011 Sale$1.9610,00019,614681,294Dec 19, 2011, 06:20 PM
LADD ROBERTDirectorDec 15, 2011 Sale$2.0110,00020,114691,294Dec 15, 2011, 05:37 PM
LADD ROBERTDirectorDec 14, 2011 Sale$2.0910,00020,900701,294Dec 15, 2011, 05:37 PM
LADD ROBERTDirectorDec 12, 2011 Sale$2.3010,00023,000721,294Dec 13, 2011, 09:11 PM
LADD ROBERTDirectorDec 13, 2011 Sale$2.2810,00022,800711,294Dec 13, 2011, 09:11 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Aharon GilDirector03/19/2024100,001
SALAMON STEVEN A JDirector03/19/2024100,001
Vukovic VojoCHIEF MEDICAL OFFICER03/19/2024100,001
MICHEL GERARD JCHIEF EXECUTIVE OFFICER03/19/2024150,002
Pennell SandraSVP OF FINANCE, PFO AND PAO03/19/202499,997
Muir KevinGM INTERVENTIONAL ONCOLOGY03/19/202450,001
Hoffman David L.GEN'L COUNSEL, CCO & SECY03/19/202474,999
Vukovic VojoChief Medical Officer12/12/2023120,000
MICHEL GERARD JChief Executive Officer12/08/202399,960
Rosalind Advisors, Inc.Director11/17/2023240,410
Pennell SandraSVP of Finance, PFO and PAO11/17/202372,900
Vukovic VojoChief Medical Officer11/16/2023148,800
Hoffman David L.See Remarks11/16/202399,200
Purpura JohnChief Operating Officer10/13/202349,897
Sylvester John RichardDirector08/21/202350,640
MICHEL GERARD JChief Executive Officer08/18/2023139,995
MICHEL GERARD JChief Executive Officer03/29/202395,087
Rosalind Advisors, Inc.Director12/14/202255,045
SALAMON STEVEN A JDirector12/14/202255,045
MICHEL GERARD JChief Executive Officer12/13/2022150,003
MICHEL GERARD JChief Executive Officer07/20/2022250,000
Purpura JohnChief Operating Officer05/16/202215,213
SALAMON STEVEN A JDirector05/13/202225,135
SALAMON STEVEN A JDirector05/12/202229,424
Rosalind Advisors, Inc.Director04/19/202210,000
SALAMON STEVEN A JDirector04/19/202210,000
Rosalind Advisors, Inc.Director04/18/202212,697
Aharon GilDirector04/18/202212,697
MICHEL GERARD JSee Remarks04/18/202212,734
Rosalind Advisors, Inc.Director04/13/20229,675
SALAMON STEVEN A JDirector04/13/20229,675
Rosalind Advisors, Inc.Director04/12/202216,200
SALAMON STEVEN A JDirector04/12/202216,200
Purpura JohnChief Operating Officer04/11/202232,950
MICHEL GERARD JSee Remarks04/08/202213,136
SALAMON STEVEN A JDirector04/07/20226,410
SALAMON STEVEN A JDirector04/06/20226,490
Rosalind Advisors, Inc.Director04/07/20226,410
Rosalind Advisors, Inc.Director04/06/20226,490
Purpura JohnChief Operating Officer11/19/202020,288
SALAMON STEVEN A JDirector12/30/202115,120
Rosalind Advisors, Inc.Director12/30/202115,120
MICHEL GERARD JSee Remarks12/02/2021199,752
SALAMON STEVEN A JDirector06/30/202170,180
Rosalind Advisors, Inc.Director06/30/202170,180
Rosalind Advisors, Inc.Director06/28/202157,800
SALAMON STEVEN A JDirector06/28/202157,800
Rosalind Advisors, Inc.Director06/28/20215,780,000
MICHEL GERARD JChief Executive Officer06/28/202174,563
MICHEL GERARD JChief Executive Officer06/25/202174,910
SALAMON STEVEN A JDirector06/24/202149,050
Purpura JohnChief Operating Officer05/13/202137,680
SALAMON STEVEN A JDirector03/31/20212,150,000
Rosalind Advisors, Inc.Director03/31/20212,150,000
Aharon GilDirector03/31/20212,150,000
MICHEL GERARD JChief Executive Officer12/11/202099,375
Purpura JohnChief Operating Officer11/19/202020,288
Rosalind Advisors, Inc.Director11/17/202030,280
SALAMON STEVEN A JDirector11/17/202030,280
Rosalind Advisors, Inc.Director11/13/202047,000
Aharon GilDirector11/16/202024,000
SALAMON STEVEN A JDirector11/13/202023,020
Purpura JohnEVP, Global Operations09/28/20189,625
STOLL ROGER G PHDDirector09/28/20188,575
Simpson Jennifer K.President & CEO09/28/201812,948
Keck BarbraChief Financial Officer09/28/201812,948
Rueckert William DodgeDirector09/28/201811,375
STOLL ROGER G PHDDirector08/01/20182,466
Rueckert William DodgeDirector07/31/20188,103
Keck BarbraChief Financial Officer08/01/2018239
Simpson Jennifer K.President & CEO07/31/2018255
Simpson Jennifer K.President & CEO06/27/2017102
Purpura JohnEVP, Regulatory Affairs06/27/201750
Keck BarbraChief Financial Officer06/27/201737
Keck BarbraSenior VP, Finance06/16/20162,140
Purpura JohnEVP, Regulatory Affairs06/16/20162,935
Simpson Jennifer K.President & CEO06/16/20166,001
STOLL ROGER G PHDDirector07/27/201510,740
Taglietti MarcoDirector07/28/201554,433
Taglietti MarcoDirector07/27/201552,350
Philips Laura ADirector07/23/201545,333
Philips Laura ADirector07/22/201535,376
Rueckert William DodgeDirector07/22/20159,580
LEUNG GABRIELDirector06/15/201211,761
Philips Laura ADirector06/01/201298,049
WATSON DOUGLAS GDirector06/01/201275,275
Koplewicz Harold SDirector06/01/201299,454
Purpura JohnEVP Reg. Affairs/Quality Assur06/01/20127,450
HOBBS EAMONN PPresident and CEO06/01/201210,611
Simpson Jennifer K.Exec. VP, Global Marketing06/01/20124,470
Miao Graham GExec. V.P., CFO05/31/201230,000
Kandarpa KrishnaExec. V.P., Chief Medical Off.01/06/2012129,790
LADD ROBERTDirector12/23/201124,660
LADD ROBERTDirector12/22/201124,421
LADD ROBERTDirector12/20/201119,500
LADD ROBERTDirector12/21/201120,000
LADD ROBERTDirector12/19/201119,185
LADD ROBERTDirector12/16/201119,614
LADD ROBERTDirector12/15/201120,114
LADD ROBERTDirector12/14/201120,900
LADD ROBERTDirector12/12/201123,000
LADD ROBERTDirector12/13/201122,800
Load More Insider Transactions
FUNDS WITH A POSITION IN DELCATH SYSTEMS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
VIVO CAPITAL, LLC855,1910.29%-53.9%Other
GEODE CAPITAL MANAGEMENT, LLC169,6020.00007%8.09%Other
BLACKROCK INC.91,9320.00001%98.09%Other
CHANGE IN SHARES OUTSTANDING FOR DELCATH SYSTEMS INC
STOCK BUYBACKS FOR DELCATH SYSTEMS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
-9.14%
1Q
12/31/2023
03/31/2023
39.64%
3Q
12/31/2023
09/30/2022
76.11%
5Q

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
-9.14%
1Q
03/31/2023
39.64%
3Q
09/30/2022
76.11%
5Q
BUYBACK ANNOUNCEMENT(S) FOR DELCATH SYSTEMS INC
LOADING...